Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial"

Circulation. 2020 Apr 14;141(15):e748-e749. doi: 10.1161/CIRCULATIONAHA.120.045964. Epub 2020 Apr 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug-Eluting Stents*
  • Everolimus
  • Humans
  • Magnesium
  • ST Elevation Myocardial Infarction* / diagnosis
  • ST Elevation Myocardial Infarction* / surgery
  • Sirolimus / adverse effects

Substances

  • Everolimus
  • Magnesium
  • Sirolimus